Barclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $750

Barclays analyst Luke Sergott has maintained an Overweight rating on Thermo Fisher Scientific (NYSE: TMO) and increased the price target from $650 to $750. This adjustment reflects a positive outlook on the company's performance.